An ABHI survey has revealed that over half of the UK’S MedTech companies anticipate exports to the Middle East to increase over the next five years.
The business survey, compiled by the UK’s MedTech trade association, found that 51% of members anticipate improved turnover in the region.
With an ageing population and longer life expectancy, there is demand for innovative UK MedTech products in the Middle East. The region’s governments have also indicated the desire to stimulate sectors outside of oil. Increased funding suggests the health sector will continue to grow, making it an attractive market for UK companies.
The announcement comes as 200 British companies prepare to travel to the UAE to exhibit at the UK Pavilion in Arab Health 2018 – the largest healthcare exhibition in the region.
Held in Dubai from 29 January to 1 February, the exhibition offers a global platform for the world’s leading manufacturers, wholesalers and distributors to meet with the scientific community in the Middle East and subcontinent to discuss business and develop new partnerships.
The UK is a key player in the drive to improve patient care around the world through the development and implementation of new technologies. Paul Benton, Managing Director, International at ABHI, said: “When we consider the substantial investment into public health from the government of the UAE, and wider Middle East, opportunities for UK companies providing value-based healthcare solutions are significant.
“With so many companies planning to increase their presence in the region, Arab Health is the ideal platform to drive this growth and the UK Pavilion promises to be a hub of activity.”